登录

DataHorizzon Research表示,到2032年,海洋生物技术市场将达到133亿美元

Marine Biotechnology Market To Reach USD 13.3 Billion By 2032, Says DataHorizzon Research

GlobeNewswire | 2024-05-04 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


Fort Collins, Colorado, May 04, 2024 (GLOBE NEWSWIRE) -- The advantages of marine biotechnology encourage industry development. Marine biotechnology encompasses a wide array of applications, ranging from drug discovery to aquaculture and regenerative medicine. Exploring the ocean's vast biodiversity has unlocked a treasure trove of bioactive compounds and biomaterials with immense potential for various industries.

科林斯堡,科罗拉多州,2024年5月4日(环球通讯社)——海洋生物技术的优势促进了产业发展。海洋生物技术包括广泛的应用,从药物发现到水产养殖和再生医学。探索海洋巨大的生物多样性开启了生物活性化合物和生物材料的宝库,为各种行业带来了巨大潜力。

Marine organisms have proven to be a rich source of bioactive compounds with therapeutic properties in drug discovery. The defense mechanisms of aquatic organisms, such as sponges, corals, and algae, have evolved to produce compounds that can combat predators and pathogens in their underwater environments.

海洋生物已被证明是具有药物发现治疗特性的生物活性化合物的丰富来源。海绵、珊瑚和藻类等水生生物的防御机制已经进化为产生能够在其水下环境中对抗捕食者和病原体的化合物。

Researchers have been able to harness these compounds for the development of novel pharmaceutical drugs targeting a range of diseases, including cancer, infectious diseases, and inflammatory disorders. The unique chemical structures of these marine-derived compounds often offer advantages over traditional drug molecules, making them promising candidates for further research and development.

研究人员已经能够利用这些化合物开发针对一系列疾病的新型药物,包括癌症,传染病和炎症性疾病。这些海洋衍生化合物的独特化学结构通常比传统药物分子具有优势,使其成为进一步研究和开发的有希望的候选者。

Moreover, marine biotechnology contributes to advancements in wound healing and regenerative medicine. Biomaterials derived from marine sources, such as chitosan extracted from crustacean shells, exhibit properties that promote tissue repair and regeneration. Chitosan's biocompatibility and biodegradability make it an ideal material for wound dressings and scaffolds for tissue engineering applications.

此外,海洋生物技术有助于伤口愈合和再生医学的进步。源自海洋来源的生物材料,例如从甲壳类动物壳中提取的壳聚糖,具有促进组织修复和再生的特性。壳聚糖的生物相容性和生物降解性使其成为组织工程应用的伤口敷料和支架的理想材料。

Clinical products utilizing chitosan-based wound dressings are already available, demonstrating the practical applications of marine-derived biomaterials in healthcare settings.  Request Sample Report:  https://bit.ly/4a4cbD4 Segmentation Overview: The marine biotechnolo.

利用壳聚糖基伤口敷料的临床产品已经可用,证明了海洋衍生生物材料在医疗保健环境中的实际应用。请求示例报告:https://bit.ly/4a4cbD4细分概述:海洋生物技术。

推荐阅读

这一医科大学

思宇MedTech 2024-05-19 00:29

华东医药:旗下3款“重磅进口”医美产品“国内临床”取得新进展

医美部落 2024-05-19 00:04

eGastroenterology:肠炎久不愈,益生元来助力

MedSci 2024-05-19 00:02

GlobeNewswire

8167篇

最近内容 查看更多

NASDAQ:NARI:Kessler Topaz Meltzer&Check,LLP通知投资者对Inari Medical,股份有限公司提起的证券集体诉讼

2 小时后

Intercept提供了新数据,证明OCA-苯扎贝特联合治疗对2024年消化道疾病周治疗六个月后ALP和代谢结果的影响

27 分钟前

Athira Pharma宣布拟议解决股东衍生诉讼

15 小时前

产业链接查看更多

所属赛道

支架
可降解支架是冠脉介入技术的最新发展方向,因具有能够避免金属支架长期存在造成的冠状动脉金属化等优势,被誉为经皮冠状动脉介入治疗领域的第4次变革。